Results 181 to 190 of about 235,727 (237)

Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Gómez-Ochoa SA, Rojas LZ, Alarcón Meléndez LJ, Quintero Santana MA, Becerra-Motta LP, Serrano-García AY, Echeverría LE.   +6 more
europepmc   +1 more source

Assessment of Plasma Exovesicles and Prothrombotic Biomarkers Suggest Prethrombotic Conditions in Chagas Cardiomyopathy in Colombia. [PDF]

Clin Appl Thromb Hemost
Jaimes-Dueñez JE, Álvarez K, Eduardo-Echeverria L, Cáceres-Rivera DI, Rojas LZ, Gómez-Ochoa SA, Daniela-Muñoz L, Cantillo-Reines M, Tique-Oviedo M, Eresbey-Granada Y, Triana-Chávez Biol O.   +10 more
europepmc   +1 more source

Chagas cardiomyopathy in Boston, Massachusetts: Identifying disease and improving management after community and hospital-based screening. [PDF]

PLoS Negl Trop Dis
Reifler KA, Wheelock A, Hall SM, Salazar A, Hassan S, Bostrom JA, Barnett ED, Carrion M, Hochberg NS, Hamer DH, Gopal DM, Bourque D.   +11 more
europepmc   +1 more source

Correlation of blood-based immune molecules with cardiac gene expression profiles reveals insights into Chagas cardiomyopathy pathogenesis. [PDF]

Front Immunol
Souza-Silva TG, Neves EGA, Koh C, Teixeira-Carvalho A, Araújo SS, Nunes MDCP, Gomes JAS, Gollob KJ, Dutra WO.   +8 more
europepmc   +1 more source

Pathogenesis of Chagas disease cardiomyopathy

World Journal of Clinical Infectious Diseases, 2012
openaire   +1 more source

Redox-Immunological Imbalance Drives Progression of Chagas Cardiomyopathy: Superoxide Dismutase as a Candidate Biomarker

Azul Pieralisi, Federico Penas, Ignacio Mazzitelli, Silvia Repetto, Monica Gili, Juan Gagliardi, Nora Goren, Agata Carolina Cevey   +7 more
openalex   +1 more source

Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial. [PDF]

Sci Rep
Vieira MC, Mendes FSNS, da Silva PS, da Silva GMS, Mazzoli-Rocha F, de Sousa AS, Saraiva RM, de Holanda MT, Kasal DAB, Costa HS, Borges JP, Reis MS, Rodrigues Junior LF, Hasslocher-Moreno AM, do Brasil PEAA, Mediano MFF.   +15 more
europepmc   +1 more source

ERRATUM: Chagas Disease Cardiomyopathy

, 2019
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Chagas Disease: Chronic Chagas Cardiomyopathy

Current Problems in Cardiology, 2021
Chagas disease (CD) is a tropical vector-borne infection caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), also known as American Trypanosomiasis. It is considered endemic in all South and Central America and in this past decades its becoming a burden particularly in the United States and Europe due to human migration. The vast majority of
Natalia Giraldo Echavarría, Luis E. Echeverría, Merrill Stewart, Catalina Gallego, Clara Saldarriaga   +4 more
openaire   +3 more sources

Chagas’ cardiomyopathy

The EACVI Textbook of Cardiovascular Magnetic Resonance, 2018
Abstract Chagas’ cardiomyopathy is a major complication emerging from Trypanosoma cruzi infection, appearing in up to 30% of individuals with positive serology and being the principal cause of death from heart failure in some areas of South America.
Carlos Eduardo Rochitte, Otávio Rizzi Coelho-Filho   +1 more
openaire   +2 more sources